These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18823340)

  • 1. Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease.
    Peace AJ; Tedesco AF; Foley DP; Dicker P; Berndt MC; Kenny D
    J Thromb Haemost; 2008 Dec; 6(12):2027-34. PubMed ID: 18823340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel discontinuation and platelet reactivity following coronary stenting.
    Mylotte D; Peace AJ; Tedesco AT; Mangiacapra F; Dicker P; Kenny D; Foley DP
    J Thromb Haemost; 2011 Jan; 9(1):24-32. PubMed ID: 20961396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
    Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
    Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Sartori C; Nardin M; Schaffer A; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Platelets; 2016 Sep; 27(6):576-82. PubMed ID: 27540959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
    Guthikonda S; Alviar CL; Vaduganathan M; Arikan M; Tellez A; DeLao T; Granada JF; Dong JF; Kleiman NS; Lev EI
    J Am Coll Cardiol; 2008 Aug; 52(9):743-9. PubMed ID: 18718422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antiplatelet effect of loading dose of clopidogrel versus abciximab during coronary intervention.
    Claeys MJ; Van Der Planken MG; Michiels JJ; Vertessen F; Dilling D; Bosmans JM; Vrints CJ
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):283-8. PubMed ID: 12032392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.
    Dropinski J; Jakiela B; Sanak M; Wegrzyn W; Biernat M; Dziedzina S; Plutecka H; Szczeklik A
    Thromb Haemost; 2007 Jul; 98(1):201-9. PubMed ID: 17598014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of high on-aspirin platelet reactivity in high-risk vascular patients treated with single or dual antiplatelet therapy.
    Amsallem M; Manzo-Silberman S; Dillinger JG; Sideris G; Voicu S; Bal dit Sollier C; Drouet L; Henry P
    Am J Cardiol; 2015 May; 115(9):1305-10. PubMed ID: 25759104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.
    Eikelboom JW; Hankey GJ; Thom J; Claxton A; Yi Q; Gilmore G; Staton J; Barden A; Norman PE
    J Thromb Haemost; 2005 Dec; 3(12):2649-55. PubMed ID: 16359503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel.
    Sibbing D; von Beckerath O; Schömig A; Kastrati A; von Beckerath N
    J Thromb Haemost; 2006 Dec; 4(12):2566-8. PubMed ID: 16938125
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
    Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'.
    Michelson AD; Linden MD; Furman MI; Li Y; Barnard MR; Fox ML; Lau WC; McLaughlin TJ; Frelinger AL
    J Thromb Haemost; 2007 Jan; 5(1):75-81. PubMed ID: 17002661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
    Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
    Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
    Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
    Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition.
    Badr Eslam R; Lang IM; Kaider A; Panzer S
    Transl Res; 2013 May; 161(5):414-20. PubMed ID: 23313628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
    Matetzky S; Shenkman B; Guetta V; Shechter M; Beinart R; Goldenberg I; Novikov I; Pres H; Savion N; Varon D; Hod H
    Circulation; 2004 Jun; 109(25):3171-5. PubMed ID: 15184279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy.
    Bobbert P; Stellbaum C; Steffens D; Schütte C; Bobbert T; Schultheiss HP; Rauch U
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):723-8. PubMed ID: 23135379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy.
    Wadowski PP; Eichelberger B; Kopp CW; Pultar J; Seidinger D; Koppensteiner R; Lang IM; Panzer S; Gremmel T
    J Cardiovasc Transl Res; 2017 Aug; 10(4):359-367. PubMed ID: 28425039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin non-responsiveness in Korean subjects on dual anti-platelet treatment determined by two different platelet function assays.
    Lee YW; Cho YH; Kim YH; Na JS; Shin HB; Ki CS; Choi TY; Lee YK
    Ann Clin Lab Sci; 2008; 38(2):126-31. PubMed ID: 18469357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.